These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9231074)
1. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Vrionis FD; Wu JK; Qi P; Waltzman M; Cherington V; Spray DC Gene Ther; 1997 Jun; 4(6):577-85. PubMed ID: 9231074 [TBL] [Abstract][Full Text] [Related]
2. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
3. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455 [TBL] [Abstract][Full Text] [Related]
4. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma. Ghoumari AM; Mouawad R; Zerrouqi A; Nizard C; Provost N; Khayat D; Naus CC; Soubrane C Gene Ther; 1998 Aug; 5(8):1114-21. PubMed ID: 10326035 [TBL] [Abstract][Full Text] [Related]
5. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Elshami AA; Saavedra A; Zhang H; Kucharczuk JC; Spray DC; Fishman GI; Amin KM; Kaiser LR; Albelda SM Gene Ther; 1996 Jan; 3(1):85-92. PubMed ID: 8929915 [TBL] [Abstract][Full Text] [Related]
6. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy. Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427 [TBL] [Abstract][Full Text] [Related]
7. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C; Bergeron C; Lane D; Garon G; Piché A Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells. Namba H; Iwadate Y; Kawamura K; Sakiyama S; Tagawa M Cancer Gene Ther; 2001 Jun; 8(6):414-20. PubMed ID: 11498761 [TBL] [Abstract][Full Text] [Related]
9. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy. Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy. Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323 [TBL] [Abstract][Full Text] [Related]
11. Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy. Duflot-Dancer A; Piccoli C; Rolland A; Yamasaki H; Mesnil M Gene Ther; 1998 Oct; 5(10):1372-8. PubMed ID: 9930343 [TBL] [Abstract][Full Text] [Related]
12. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma]. Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035 [TBL] [Abstract][Full Text] [Related]
13. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
14. Connexin 43-mediated bystander effect in two rat glioma cell models. Sanson M; Marcaud V; Robin E; Valéry C; Sturtz F; Zalc B Cancer Gene Ther; 2002 Feb; 9(2):149-55. PubMed ID: 11857032 [TBL] [Abstract][Full Text] [Related]
15. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect. Princen F; Robe P; Lechanteur C; Mesnil M; Rigo JM; Gielen J; Merville MP; Bours V Clin Cancer Res; 1999 Nov; 5(11):3639-44. PubMed ID: 10589781 [TBL] [Abstract][Full Text] [Related]
16. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect. Wygoda MR; Wilson MR; Davis MA; Trosko JE; Rehemtulla A; Lawrence TS Cancer Res; 1997 May; 57(9):1699-703. PubMed ID: 9135011 [TBL] [Abstract][Full Text] [Related]
17. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Bi W; Kim YG; Feliciano ES; Pavelic L; Wilson KM; Pavelic ZP; Stambrook PJ Cancer Gene Ther; 1997; 4(4):246-52. PubMed ID: 9253510 [TBL] [Abstract][Full Text] [Related]
18. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783 [TBL] [Abstract][Full Text] [Related]
19. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027 [TBL] [Abstract][Full Text] [Related]
20. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines. Imaizumi K; Hasegawa Y; Kawabe T; Emi N; Saito H; Naruse K; Shimokata K Am J Respir Cell Mol Biol; 1998 Feb; 18(2):205-12. PubMed ID: 9476907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]